Want to see GOSS full AI Analyst Report?
Total Valuation
Gossamer Bio has a market cap or net worth of $85.55M. The enterprise value is $203.89M.
Market Cap$85.55M
Enterprise Value$203.89M
Share Statistics
Gossamer Bio has 488,846,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding488,846,700
Owned by Insiders1.86%
Owned by Institutions0.22%
Financial Efficiency
Gossamer Bio’s return on equity (ROE) is 1.39 and return on invested capital (ROIC) is -148.67%.
Return on Equity (ROE)1.39
Return on Assets (ROA)-0.99
Return on Invested Capital (ROIC)-148.67%
Return on Capital Employed (ROCE)-1.50
Revenue Per Employee299.20K
Profits Per Employee-1.05M
Employee Count162
Asset Turnover0.28
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Gossamer Bio is ―. Gossamer Bio’s PEG ratio is -0.02.
PE Ratio―
PS Ratio14.62
PB Ratio-5.77
Price to Fair Value-5.77
Price to FCF-4.13
Price to Operating Cash Flow-0.23
PEG Ratio-0.02
Income Statement
In the last 12 months, Gossamer Bio had revenue of 48.47M and earned -170.37M in profits. Earnings per share was -0.75.
Revenue48.47M
Gross Profit47.47M
Operating Income-163.25M
Pretax Income-170.46M
Net Income-170.37M
EBITDA-158.47M
Earnings Per Share (EPS)-0.75
Cash Flow
In the last 12 months, operating cash flow was -170.26M and capital expenditures -53.00K, giving a free cash flow of -170.32M billion.
Operating Cash Flow-170.26M
Free Cash Flow-170.32M
Free Cash Flow per Share-0.35
Dividends & Yields
Gossamer Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.48
52-Week Price Change-87.57%
50-Day Moving Average0.22
200-Day Moving Average1.57
Relative Strength Index (RSI)42.86
Average Volume (3m)15.66M
Important Dates
Gossamer Bio upcoming earnings date is Aug 11, 2026, After Close (Confirmed).
Last Earnings DateMay 18, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
Gossamer Bio as a current ratio of 2.64, with Debt / Equity ratio of -125.67%
Current Ratio2.64
Quick Ratio2.64
Debt to Market Cap0.28
Net Debt to EBITDA-1.04
Interest Coverage Ratio-14.86
Taxes
In the past 12 months, Gossamer Bio has paid -88.00K in taxes.
Income Tax-88.00K
Effective Tax Rate<0.01
Enterprise Valuation
Gossamer Bio EV to EBITDA ratio is -5.51, with an EV/FCF ratio of -5.10.
EV to Sales18.02
EV to EBITDA-5.51
EV to Free Cash Flow-5.10
EV to Operating Cash Flow-5.10
Balance Sheet
Gossamer Bio has $99.22M in cash and marketable securities with $202.93M in debt, giving a net cash position of -$103.72M billion.
Cash & Marketable Securities$99.22M
Total Debt$202.93M
Net Cash-$103.72M
Net Cash Per Share-$0.21
Tangible Book Value Per Share-$0.54
Margins
Gross margin is 99.58%, with operating margin of -336.81%, and net profit margin of -351.49%.
Gross Margin99.58%
Operating Margin-336.81%
Pretax Margin-351.67%
Net Profit Margin-351.49%
EBITDA Margin-326.93%
EBIT Margin-329.00%
Analyst Forecast
The average price target for Gossamer Bio is $1.09, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$1.09
Price Target Upside142.96% Upside
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast-55.42%
EPS Growth Forecast-248.85%